[ad_1] Interviewed in May’s issue of @RetinalPhys on “Industry Opportunities for Retina Specialists”. As Dr. Chang aptly states, “It takes an army of people with significant know-how and expertise, working together, to develop sight-saving drugs or technologies.” https://t.co/gVyH8I2kwv [ad_2] Source by Thomas Ciulla, MD, MBA …
[ad_1] Interviewed in May’s issue of Retinal Physician – “Industry Opportunities for Retina Specialists” https://t.co/Fcp0TOAAIf [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
Just co-authored: Retinal Physician – Targeting RNA for Retinal Disease https://t.co/u5tkg8AVOA
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Just co-authored: Retinal oximetry may further the understanding of common vascular and ischemic disorders, including glaucoma, diabetic retinopathy, vein occlusions… Retinal oximetry in glaucoma: investigations and findings reviewed https://t.co/HQFJg48dAC [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] Fauci on remdesivir for COVID-19: ‘This will be the standard of care’ https://t.co/iNKIdA4zS7 [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
Proud of my team members Viral Kansara, PhD and Leroy Muya, PhD who were asked to present on Suprachoroidal Delivery at an upcoming conference “Gene Therapy for Ophthalmic Disorders”, in Boston, August 5 & 6:
https://t.co/fPipiEfIfb
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Risks of turning to homemade cleaning products amid COVID-19 https://t.co/KM0I7018BA [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] RT @ophthopedia: Ophthopedia Update: Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Pha… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
RT @ophthopedia: Ophthopedia Update: Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analys…
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Just published….Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases… https://t.co/f25J5fPLea [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.